Kinclav™-625 LB is a combination antibiotic containing Amoxicillin and Clavulanic Acid, along with Lactic Acid Bacillus. Amoxicillin works against susceptible bacteria, while clavulanic acid helps protect amoxicillin from certain bacterial beta-lactamases. Lactic Acid Bacillus is included to support the balance of intestinal flora during antibiotic treatment.
Composition
Each film-coated tablet contains:
- Amoxicillin Trihydrate equivalent to Amoxicillin — 500 mg
- Potassium Clavulanate equivalent to Clavulanic Acid — 125 mg
- Lactic Acid Bacillus — 60 Million Spores
- Excipients — q.s.
The 500 mg/125 mg antibiotic combination with 60 million spores is consistent with published product information for this formulation.
Key Features
Dual antibacterial action: Amoxicillin combined with clavulanic acid provides activity against susceptible bacteria, including certain beta-lactamase-producing organisms.
